immunaut AI platform for vaccine immunogenicity prediction

Celebrating CEIRR Award for Atomic Lab’s Immunaut

January, 2025.

We are thrilled to announce that Ivan, Head of Data Science at Atomic Lab, has received a prestigious CEIRR (Centers of Excellence for Influenza Research and Response) award for his outstanding work on Immunaut, our novel AI platform designed to predict vaccine immunogenicity. This achievement highlights Immunaut’s power to provide a holistic view of the Live Attenuated Influenza Vaccine (LAIV) immune response – especially in children.

This AI immunology LAIV vaccine project targets LAIV by analyzing a comprehensive dataset from 244 Gambian children. Our goal is to uncover how different immune landscapes influence vaccine responses.

Immunaut uses machine learning to integrate humoral, mucosal, cellular, transcriptomic, and microbiological data. By doing so, it reveals distinct immunophenotypes – such as mucosal responders and memory T-cell responders – that affect the outcome of LAIV vaccination. Our team believes this AI-powered approach will lead to personalized vaccine strategies, which are vital for preventing future pandemics and improving global health.

We collaborate with renowned experts, including Florian Krammer and Thushan I de Silva, to explore how AI can enhance immunology and refine vaccines. The insights we gain help us pinpoint the immune components needed for stronger and longer-lasting protection. Our findings are already shaping new methods to boost vaccine coverage across diverse populations.

Through his recent CEIRR interview, Ivan shared insights into the platform’s development, its potential to transform influenza research, and his passion for applying cutting-edge technology to enhance vaccine effectiveness.

Bravo to Ivan and the entire Atomic Lab team for this remarkable milestone. We look forward to advancing AI-driven immunology and vaccine research, thanks to support from the CEIRR network and our incredible collaborators around the globe!

Interested in our broader mission? Visit Atomic Lab’s official site to learn more about our breakthroughs in AI, immunology, and next-generation vaccines, and for other open-source computational tools we are developing visit Atomic Lab Software.

We appreciate the unwavering support from CEIRR and look forward to sharing more updates as we continue developing AI immunology LAIV vaccine solutions that can transform the future of healthcare.

You May Also Like…